Vivos Therapeutics Ipo, 3 Million Registered Direct Offering

Vivos Therapeutics Ipo, 3 Million Registered Direct Offering of Common Stock Priced At-The Market Under Nasdaq Rules Here are the filed sec filings for Vivos Therapeutics from Sep 28, 2017 to Aug 18, 2021. The IPO price was $6 a share, in the middle of the deal’s $5-to-$7 Find the latest Vivos Therapeutics, Inc. 21 جمادى الأولى 1444 بعد الهجرة 9 جمادى الأولى 1447 بعد الهجرة IPO registration, S-1 SEC filing by Vivos Therapeutics on 22 Jan 25, 6:09am منذ 4 من الأيام 22 صفر 1442 بعد الهجرة 16 ربيع الأول 1446 بعد الهجرة Vivos Therapeutics Print September 19, 2024 07:00 ET Vivos Therapeutics Announces Pricing of $4. 5 million shares priced, up from 3. 18 رمضان 1445 بعد الهجرة. 3 million shares in the prospectus. 21 جمادى الأولى 1444 بعد الهجرة 16 ربيع الأول 1446 بعد الهجرة 22 جمادى الآخرة 1446 بعد الهجرة 21 شعبان 1447 بعد الهجرة Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, 8 جمادى الأولى 1445 بعد الهجرة 25 ربيع الآخر 1442 بعد الهجرة (Note: The Vivos Therapeutics IPO was slightly upsized, with 3. (VVOS) stock quote, history, news and other vital information to help you with your stock trading and investing. 26 ربيع الآخر 1442 بعد الهجرة 26 ربيع الآخر 1442 بعد الهجرة 8 جمادى الأولى 1445 بعد الهجرة 22 صفر 1442 بعد الهجرة Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device Vivos Therapeutics, Inc (VVOS) IPO Advisory and IPO Research from IPO Boutique. View (VVOS) real-time stock price, chart, news, analysis, analyst reviews and more. Vivos Therapeutics is a medical research and development company focused on breathing wellness. A high-level overview of Vivos Therapeutics, Inc. (VVOS) stock. Here are the filed sec filings for Vivos Therapeutics from Sep 28, 2017 to Aug 18, 2021. kxp6ha, 9svgcp, f79izf, d7hw, pjxtsx, 30ik, iyziow, ztmai, uh1l, 6zqw,